SCOPUS 정보 검색 플랫폼

The Lancet

Volumn 379, Issue 9813, 2012, Pages 291-292

Adjuvant therapy for gastric cancer after D2 gastrectomy

(1) Nishida, Toshirou a,b

a OSAKA POLICE HOSPITAL (Japan)

b OSAKA UNIVERSITY (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; OXALIPLATIN; TRASTUZUMAB;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DRUG WITHDRAWAL; GASTRECTOMY; HUMAN; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT OUTCOME;

EID: 84856404626 PISSN: 01406736 EISSN: 1474547X Source Type: Journal
DOI: 10.1016/S0140-6736(11)61928-4 Document Type: Note

Times cited : (32)

References (5)

1
- 84982289409
- Benefit of adjuvant chemotherapy for resectable gastric cancer: A meta-analysis
- GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group
- GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group X Paoletti, K Oba, T Burzykowski et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis JAMA 303 2010 1729 1737
- (2010) JAMA , vol.303 , pp. 1729-1737
- Paoletti, X.¹ Oba, K.² Burzykowski, T.³

2
- 35748946650
- Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
- DOI 10.1056/NEJMoa072252
- S Sakuramoto, M Sasako, T Yamaguchi et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 2007 1810 1820 (Pubitemid 350044801)
- (2007) New England Journal of Medicine , vol.357 , Issue.18 , pp. 1810-1820
- Sakuramoto, S.¹ Sasako, M.² Yamaguchi, T.³ Kinoshita, T.⁴ Fujii, M.⁵ Nashimoto, A.⁶ Furukawa, H.⁷ Nakajima, T.⁸ Ohashi, Y.⁹ Imamura, H.¹⁰ Higashino, M.¹¹ Yamamura, Y.¹² Kurita, A.¹³ Arai, K.¹⁴

3
- 0035818048
- Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
- JS Macdonald, SR Smalley, J Benedetti et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
- (2001) N Engl J Med , vol.345 , pp. 725-730
- MacDonald, J.S.¹ Smalley, S.R.² Benedetti, J.³

4
- 84856382467
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): A phase 3 open-label, randomised controlled trial
- for the CLASSIC trial investigators 10.1016/S0140-6736(11)61873-4 published online Jan 7
- Y-J Bang, Y-W Kim, H-K Yang for the CLASSIC trial investigators Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 2012 10.1016/S0140-6736(11)61873-4 published online Jan 7.
- (2012) Lancet
- Bang, Y.-J.¹ Kim, Y.-W.² Yang, H.-K.³

5
- 81755171104
- Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer
- M Sasako, S Sakuramoto, H Katai et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer J Clin Oncol 29 2011 4387 4393
- (2011) J Clin Oncol , vol.29 , pp. 4387-4393
- Sasako, M.¹ Sakuramoto, S.² Katai, H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.